Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2004-04-01
2010-06-15
Helms, Larry R. (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007230, C530S387100
Reexamination Certificate
active
07736856
ABSTRACT:
It is intended to provide a novel method of screening a drug with the use of a 67 kDa laminin receptor and a drug obtained thereby. A method of screening a drug having an effect on inhibiting cell proliferation, an angiogenesis inhibitory effect, an effect of inhibiting cancer cell metastasis, a neuroprotective effect, and anti-allergic effect, and anti-arteriosclerotic effect and/or an effect of inhibiting infection with Creutzfeldt-Jakob disease which involves the step of qualitatively or quantitatively measuring the degree of the binding of a test compound to a 67 kDa laminin receptor, and judging that the test compound is a drug having an effect of inhibiting cell proliferation, and angiogenesis inhibitory effect, an effect of inhibiting cancer cell metastasis, a neuroprotective effect, and anti-allergic effect, and anti-arteriosclerotic effect and/or an effect of inhibiting infection with Creutzfeldt-Jakob disease in the case where it is found out by the results of the measurement that the test compound binds to the 67 kDa laminin receptor, and a drug obtained thereby.
REFERENCES:
patent: 6410052 (2002-06-01), Morre et al.
patent: WO 99/54356 (1999-10-01), None
Zips et al, 2005, In vivo, 19: 1-8.
Lee et al, 1999, J Immunol, 163: 6292-6300.
Kirkin et al, 1998, APMIS, 106 : 665-679.
Kimmel et al, 1987 (J. Neurosurg, 66:161-171, of record).
Dermer, 1994 (Bio/Technology, 12:320).
Kaiser (Science, 2006, 313, 1370).
Gura, 1997, (Science, 278:1041-1042).
International Search Report completed May 18, 2004.
Tachibana; “A receptor for green tea polyphenol EGCG.”; Natural Structural & Molecular Biology; vol. 11, No. 4, (2004); pp. 380-381.
The Supplementary Europian Search Report dated Mar. 13, 2007, pp. 1-5.
Hou et al.: “Effects of tea polyphonols on signal transduction pathways related to cancer chemoprevention”, Mutation Research, Amsterdam, NL, vol. 555, No. 1-2, Nov. 2, 2004; pp. 3-19.
Narumi et al.: “Inhibition of experimental metastasis of human fibrosarcoma cells by anti-recombinant 37-kDa Taminin binding protein antibody”, Japanese Journal of Cancer Research, Japanese Cancer Association, Tokyo, JP, vol. 90, No. 4, Apr. 1999, pp. 425-431.
Gevarowska Dorota et al.: “Synthetic peptides interacting with the 67-kd laminin receptor can reduce retinal ischemia and inhibit hypoxia-induced retinal neovascularization”, American Journal of Pathology, vol. 160, No. 1, Jan. 2002, pp. 307-313.
Tanaka Masashi et al.: “Expression of the 37-kDa laminin binding protein in murine lung tumor cell correlates with tumor angiogenesis”, Cancer Letters, vol. 153, No. 1-2, May 29, 2000, pp. 161-168.
Koo et al.: “Pharmacological effects of green tea on the gastrointestinal system”, European Journal of Pharmacology, Amsterdam, NL., vol. 500, No. 1-3, Oct. 1, 2004, pp. 177-185.
Koo et al.: “Pharmacological effects of green tean on the gastrointestinal system”, European Journal of Pharmacology, Amsterdam, NL, vol. 500, No. 1-3, October 1, 2004, pp. 177-185.
European Office Action dated Aug. 9, 2009.
Davis Minh Tam
Helms Larry R.
Kyushu TLO Company Limited
Whitham Curtis Christofferson & Cook PC
LandOfFree
Method of screening drug with the use of 67 kDa laminin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of screening drug with the use of 67 kDa laminin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of screening drug with the use of 67 kDa laminin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4163255